400-900-4166

小鼠表面活性蛋白D检测试剂盒,BR

Mouse Surfactant protein D ELISA KIT

(订货以英文名为准)
产品编号:AC16726 品牌:Acmec

猜你喜欢

石英砂, AR,8-16目

CAS No:14808-60-7

聚乙二醇200单甲醚, 平均分子量200

CAS No:9004-74-4

4-Oxobedfordiaic acid, 分析对照品,HPLC≥98%

CAS No:68799-38-2

CAS No:115383-22-7

6-O-p-Methoxycinnamoylcatalpol, 分析对照品,HPLC≥97.5%

CAS No:121710-02-9

溴化锂, 99.5% metals basis

CAS No:7550-35-8

十六烯, 94%

CAS No:629-73-2

硼烷二甲硫醚, 2.0 M solution in THF, SafeSeal

CAS No:13292-87-0

中文名称:
小鼠表面活性蛋白D检测试剂盒
英文名称:
Mouse Surfactant protein D ELISA KIT
保存条件:
2-8℃

产品属性 Product Attributes

基本信息

中文名称: 小鼠表面活性蛋白D检测试剂盒
英文名称: Mouse SP-D ELISA Kit
别名: Surfactant protein D; Collectin 7; Lung surfactant protein D; PSPD; PSP-D; SFTP4; SFTPD; SPD; SP-D; SP-Dpulmonary surfactant apoprotein; surfactant protein D; surfactant-associated protein, pulmonary 4
储存条件: 2-8℃,6 months
规格: 96T ; 48T
检测目标: SP-D
样品类型: 血清/血浆/细胞培养上清
反应性: Mouse
应用: ELISA
定量/定性: 定量检测
检测范围: 62.5-4000pg/mL
灵敏度: 31.25pg/mL
精密度: 板内,板间变异系数均<10%
回收率: 80%-120%

Elisa信息

Swiss Prot: P50404
Gene ID: 20390
背景说明: Surfactant pulmonary-associated protein D, also known as SFTPD and SP-D, is a member of the collectin family of C-type lectins that is synthesized in many tissues including respiratory epithelial cells in the lung, and contains one C-type lectin domain and one collagen-like domain. The polymorphic variation in the N-terminal domain of the SP-D molecule influences oligomerization, function, and the concentration of the molecule in serum. SFTPD is produced primarily by alveolar type II cells and nonciliated bronchiolar cells in the lung and is constitutively secreted into the alveoli where it influences surfactant homeostasis, effector cell functions, and host defense. It is upregulated in a variety of inflammatory and infectious conditions including Pneumocystis pneumonia and asthma. SFTPD is humoral molecules of the innate immune system, and is considered a functional candidate in chronic periodontitis. Besides, it is involved in the development of acute and chronic inflammation of the lung. Several human lung diseases are characterized by decreased levels of bronchoalveolar SFTPD. Thus, recombinant SFTPD has been proposed as a therapeutical option for cystic fibrosis, neonatal lung disease and smoking-induced emphysema. Furthermore, SFTPD serum levels can be used as disease activity markers for interstitial lung diseases.

产品介绍 Product Introduction

暂无数据

注意事项 Considerations

1.本产品仅供科研使用。请勿用于医药、临床诊断或治疗,食品及化妆品等用途。请勿存放于普通住宅区。
2.为了您的安全和健康,请穿好实验服并佩戴一次性手套和口罩操作。
3.实验结果可由多种因素影响,相关处理只限于产品本身,不涉及其他赔偿。
危化品级别:
关于的化合物详细属性等信息,点击“
技术资料
DATA SHEET
历史浏览记录
​Copyright ◎ 2018 ACMEC-E.COM-版权所有,未经授权禁止拷贝本站资料,如有违反,将追究法律责任
上海吉至生化科技有限公司
沪公网安备31012002005909号   沪ICP备18007380号-1
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
危险品化学品经营许可证    营业执照(三证合一)